NS

Nortech Systems Incorporated

NSYSHealthcareNASDAQ

Medical Devices

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$118.4M
-7.6% YoY
Net Income
-$252,000
+80.5% YoY
EBITDA
$2.3M
+46.7% YoY
Free Cash Flow
$3.0M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ MACD Negative CrossoverHistogram -0.0746, negative momentum
Oct 19▼ MACD Negative CrossoverHistogram -0.0495, negative momentum
About Nortech Systems Incorporated

Part of the healthcare sector, Nortech Systems Incorporated (NSYS) is listed under Medical Devices. The $29.4M market capitalization puts NSYS squarely in micro-cap range for its industry. It offers a range of value-added engineering, technical, manufacturing, and support services, including project management, designing, testing, prototyping, manufacturing, supply chain management, and post-market services.

Where NSYS stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, NSYS finished 24.36% below its 150-day moving average ($13.26) and 17.52% below its 200-day moving average ($12.16). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is NSYS overbought or oversold?

At the October 20, 2026 close, NSYS's RSI(14) was 33.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$29.4M
P/E (TTM)28.61
EPS$0.36
Beta-0.12
52W Change+6.1%
Dividend Yield0.00%
ROE3.0%
Analysis

The company holds $1.4M in cash, though total debt stands at $17.9M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $3.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 3.0% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $134.1M (2022) to $118.4M (2025), a 12% decline worth watching.

With a beta below 0.7, Nortech Systems Incorporated typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Nortech Systems Incorporated carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing NSYS.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms